|
Jul 15
|
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
|
|
Jun 24
|
NeuroPace Announces Strategic CFO Transition
|
|
Jun 17
|
NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey
|
|
May 28
|
NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial
|
|
May 28
|
NeuroPace reports initial one-year outcomes from trial of RNS System
|
|
May 27
|
Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data?
|
|
May 27
|
NeuroPace Says Epilepsy Trial Meets Safety Goal, Misses Overall Efficacy Target
|
|
May 27
|
NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study
|
|
Apr 14
|
NeuroPace Provides Update on Tariff Status
|
|
Feb 21
|
NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains?
|
|
Feb 20
|
NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.
|
|
Feb 20
|
Integer (ITGR) Misses Q4 Earnings Estimates
|
|
Feb 19
|
NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
|
|
Feb 18
|
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
|
|
Sep 4
|
NeuroPace Strengthens Management Team with Two Key Appointments
|
|
Aug 27
|
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
|
|
Jul 31
|
Waters (WAT) Q2 Earnings and Revenues Top Estimates
|
|
Jul 23
|
NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024
|
|
May 14
|
NeuroPace to Participate in Two Healthcare Conferences in May
|
|
May 13
|
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript
|